Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
about
Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseABCB1 genetic variants in leukemias: current insights into treatment outcomesGenetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaPolymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia.Personalization of dexamethasone therapy in childhood acute lymphoblastic leukaemia.Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.Nuclear receptors and drug metabolism for the personalization of cancer therapy.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.Advances and challenges in hereditary cancer pharmacogenetics.Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.Association of ABCB1 C3435T polymorphism with the susceptibility to osteonecrosis of the femoral head: A meta-analysis.Clinical significance of the ABCB1 and ABCG2 gene expression levels in acute lymphoblastic leukemia.Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapseGenetic background influences susceptibility to chemotherapy-induced hematotoxicity.Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.ABCB1 1199G>A polymorphism (rs2229109) affects the transport of imatinib, nilotinib and dasatinib.
P2860
Q28068930-43957B4D-236F-484C-A7DD-9B35A7320302Q33707782-8AD08BA5-B8CB-4E02-A112-AD7A1B5442B8Q33774499-3A2C9546-9A79-4C50-9BAC-A3F84BF11499Q33914131-3595D23E-9C96-49F3-A8D0-F24F3DBEC263Q38686308-8D7E95F1-6EC2-4128-B2E8-AFEF0BC4876CQ38688039-23FD740E-ED26-4218-A76C-9E3EBF13ABC9Q38704025-C17734C3-E2F0-4209-89D6-B8D221001649Q38888350-324F11D9-EE58-4BA5-8374-AF98B7BFD0EDQ38895172-C6E15319-D13C-48AE-8E76-3EA0C66AB83CQ38948499-A86229C5-A4C4-435C-ACAE-396A51E1386EQ39098740-12EC95EC-8E02-402E-A31F-77CE9112712DQ39313061-3181907E-82A1-456E-A638-2DB895F6BF37Q40426902-DB029E0D-88D0-4A95-BE1C-CA2F22EB00C5Q42115117-9EBF2A96-E3FB-47E9-9BED-99568A10FDEEQ47094464-4D0DA4CA-8D51-4FE6-9321-07091B2133A1Q47310338-098633B4-05F0-4EC7-BC97-00B6B1ABDEEBQ48234027-F0B2EF90-07C6-40C0-8858-F8EE1D589374Q51717149-B68A77B9-6105-4A87-B481-98BF898FA1B2
P2860
Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Polymorphisms in the ABCB1 gen ...... d acute lymphoblastic leukemia
@ast
Polymorphisms in the ABCB1 gen ...... d acute lymphoblastic leukemia
@en
type
label
Polymorphisms in the ABCB1 gen ...... d acute lymphoblastic leukemia
@ast
Polymorphisms in the ABCB1 gen ...... d acute lymphoblastic leukemia
@en
prefLabel
Polymorphisms in the ABCB1 gen ...... d acute lymphoblastic leukemia
@ast
Polymorphisms in the ABCB1 gen ...... d acute lymphoblastic leukemia
@en
P2093
P2860
P356
P1476
Polymorphisms in the ABCB1 gen ...... d acute lymphoblastic leukemia
@en
P2093
C Peterson
H Schroeder
I J Christensen
S Rosthoej
P2860
P2888
P304
P356
10.1038/TPJ.2014.81
P577
2015-01-13T00:00:00Z